112 related articles for article (PubMed ID: 33036881)
21. Health-related Quality of Life in Children and Adolescents With β-Thalassemia Major on Different Iron Chelators in Basra, Iraq.
Abdul-Zahra HA; Hassan MK; Ahmed BA
J Pediatr Hematol Oncol; 2016 Oct; 38(7):503-11. PubMed ID: 27606437
[TBL] [Abstract][Full Text] [Related]
22. [Beta-thalassemia major in children and adolescents in Denmark].
Jung A; Main KM; Scheibel E; Peitersen B; Clausen N; Erichsen G; Schmiegelow K; Illum N
Ugeskr Laeger; 2002 Dec; 164(49):5803-6. PubMed ID: 12523224
[TBL] [Abstract][Full Text] [Related]
23. Molecular Epidemiological Investigation of Thalassemia in the Chengdu Region, Sichuan Province, Southwest China.
Yu X; Yang LY; Yang HT; Liu CG; Cao DC; Shen W; Yang H; Zhan XF; Li J; Xue BR; Lin M
Hemoglobin; 2015; 39(6):393-7. PubMed ID: 26290351
[TBL] [Abstract][Full Text] [Related]
24. Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.
Shamoon RP; Al-Allawi NA; Cappellini MD; Di Pierro E; Brancaleoni V; Granata F
Hemoglobin; 2015; 39(3):178-83. PubMed ID: 25902180
[TBL] [Abstract][Full Text] [Related]
25. Consanguinity and incidence of thalassaemia in Egypt.
Habib Z; Böök JA
Hereditas; 1983; 99(2):215-7. PubMed ID: 6668208
[No Abstract] [Full Text] [Related]
26. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.
Al-Mousawi MM; Al-Allawi NA; Alnaqshabandi R
Hemoglobin; 2015; 39(6):423-6. PubMed ID: 26327166
[TBL] [Abstract][Full Text] [Related]
27. Consanguineous unions and endogamy in families of beta-thalassaemia patients from two Mediterranean populations: Tunisia and Italy.
Weslati R; Ouederni M; Ruffo G; Khaled MB; Kouki R; Di Girgenti C; Borsellino Z; Sammartano I; El Gazzah M; El-Bok S; Bejaoui M
Ann Hum Biol; 2019 Dec; 46(7-8):610-615. PubMed ID: 31793346
[No Abstract] [Full Text] [Related]
28. Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt.
Adly AA; Ebeid FS
J Pediatr Hematol Oncol; 2015 May; 37(4):281-4. PubMed ID: 25811748
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and Molecular Characterization of Multidrug Resistant Klebsiella pneumoniae Isolated from Different Clinical Sources in Al-Najaf Province-Iraq.
Aljanaby AAJ; Alhasnawi HMRJ
Pak J Biol Sci; 2017; 20(5):217-232. PubMed ID: 29023034
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of hemoglobinopathies in a large ethnic Hakka population in southern China.
Zhao P; Wu H; Weng R
Medicine (Baltimore); 2018 Nov; 97(45):e13034. PubMed ID: 30407298
[TBL] [Abstract][Full Text] [Related]
31. Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.
Karimi M; Giti R; Haghpanah S; Azarkeivan A; Hoofar H; Eslami M
Pediatr Blood Cancer; 2009 Dec; 53(6):1064-7. PubMed ID: 19533641
[TBL] [Abstract][Full Text] [Related]
32. [Beta-thalassemia in metropolitan France].
Badens C; North ML; Lena-Russo D
Presse Med; 2003 Jun; 32(22):1016-21. PubMed ID: 12876516
[TBL] [Abstract][Full Text] [Related]
33. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.
Romphruk AV; Simtong P; Butryojantho C; Pimphumee R; Junta N; Srichai S; Komvilaisak P; Puapairoj C
Transfusion; 2019 Jan; 59(1):177-184. PubMed ID: 30443908
[TBL] [Abstract][Full Text] [Related]
34. β-Thalassemia in Abu Dhabi: consanguinity and tribal stratification are major factors explaining the high prevalence of the disease.
Denic S; Aden B; Nagelkerke N; Essa AA
Hemoglobin; 2013; 37(4):351-8. PubMed ID: 23600619
[TBL] [Abstract][Full Text] [Related]
35. SEN virus genotype H distribution in β-thalassemic patients and in healthy donors in Iraq: Molecular and physiological study.
Al-Ouqaili MTS; Majeed YH; Al-Ani SK
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0007880. PubMed ID: 32511233
[TBL] [Abstract][Full Text] [Related]
36. Changes in the epidemiology of thalassemia in North America: a new minority disease.
Vichinsky EP; MacKlin EA; Waye JS; Lorey F; Olivieri NF
Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
[TBL] [Abstract][Full Text] [Related]
37. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.
Vichinsky E; Cohen A; Thompson AA; Giardina PJ; Lal A; Paley C; Cheng WY; McCormick N; Sasane M; Qiu Y; Kwiatkowski JL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27067. PubMed ID: 29637688
[TBL] [Abstract][Full Text] [Related]
38. [Molecular epidemiological analysis of α- and β-thalassemia in Fujian province].
Xu LP; Huang HL; Wang Y; Zheng L; Wang LS; Xu JB; Huang XX; Lin Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):403-6. PubMed ID: 23926004
[TBL] [Abstract][Full Text] [Related]
39. Extended molecular spectrum of beta- and alpha-thalassemia in Oman.
Hassan SM; Hamza N; Jaffer Al-Lawatiya F; Jaffer Mohammed A; Harteveld CL; Rajab A; Giordano PC
Hemoglobin; 2010 Jan; 34(2):127-34. PubMed ID: 20353347
[TBL] [Abstract][Full Text] [Related]
40. Children with medical complexity receiving home healthcare devices in Japan: a retrospective cohort study.
Shinjo D; Yotani N; Ito A; Isayama T
BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38942589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
